Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to $58.2 million.

  • Cullinan Therapeutics' Shares Outstanding (Weighted Average) fell 6.54% to $42.8 million in Q4 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 6.31%. This contributed to the annual value of $58.2 million for FY2024, which is 36.11% up from last year.
  • As of FY2024, Cullinan Therapeutics' Shares Outstanding (Weighted Average) stood at $58.2 million, which was up 36.11% from $42.8 million recorded in FY2023.
  • Cullinan Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $58.2 million for FY2024, and its period low was $37.8 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $48.9 million, with a median of $45.8 million in 2022.
  • As far as peak fluctuations go, Cullinan Therapeutics' Shares Outstanding (Weighted Average) fell by 6.54% in 2023, and later soared by 36.11% in 2024.
  • Over the past 5 years, Cullinan Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $37.8 million in 2020, then increased by 15.47% to $43.7 million in 2021, then rose by 4.78% to $45.8 million in 2022, then fell by 6.54% to $42.8 million in 2023, then soared by 36.11% to $58.2 million in 2024.